echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Deck Pharma appoints Minyoung Kim as General Manager of Deck Korea

    Deck Pharma appoints Minyoung Kim as General Manager of Deck Korea

    • Last Update: 2021-07-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    A biopharmaceutical company dedicated to R&D and commercialization of innovative tumor therapies - Deck Pharmaceuticals Co.
    , Ltd.
    announced today that the company officially appointed Ms.
    Minyoung Kim as the general manager of Deck Korea.
    In order to further expand the Asia-Pacific market, Deck Pharmaceuticals has established a Korean subsidiary "Deqi Pharmaceutical Co.
    , Ltd.
    "

    .


    As the general manager of Deqi Korea, Minyoung will be guided by the company's vision to establish a first-class professional team and actively cooperate with local health organizations to promote the commercialization of innovative products and provide new treatment options for Korean patients

    .
    Minyoung will report directly to Thomas Karalis, Vice President and Head of Asia Pacific of Deqi Pharmaceutical Group

    .


    Minyoung is a well-recognized leader in the industry.
    She has been in the biopharmaceutical field for more than 30 years and has made outstanding achievements in product launches and channel expansion.
    In addition, she has worked with the team to develop an effective "patient-centered" Development strategy

    .
    Prior to joining Deqi, Minyoung served as the general manager of Ipsen Korea and achieved significant growth in the company's business by promoting product commercialization and organizational transformation

    .
    Minyoung has worked in Eli Lilly Korea and Asia for 13 years, holding important positions in marketing, marketing and market access, and has participated in the launch of new products in various diseases such as oncology

    .
    Before joining Eli Lilly, Minyoung worked as a pharmacist at IMS Health (now Ai Kunwei) and Seoul National University Hospital

    .


    Dr.
    Mei Jianming, Founder, Chairman and CEO of Deqi Pharmaceuticals, said: “Minyoung is a leader with extensive experience in the pharmaceutical industry.
    She has made outstanding achievements in establishing efficient organizations and driving business growth

    .
    We believe that, Her rich experience will inject new vitality into the Deqi team and create new achievements for the company

    .
    Under her leadership, Deqi Korea will achieve rapid growth and development, and better benefit Korean cancer patients

    .
    "


    Mr.
    Thomas Karalis, Vice President of Deqi Pharmaceutical Group and Head of Asia-Pacific Market, said: “Deqi's rapid expansion in the Asia-Pacific market and the establishment of the company’s business in Korea is an important milestone

    .
    I am very pleased that an outstanding leader like Minyoung has joined Deqi and became The general manager of the Korean market

    .
    I believe her rich leadership experience in Korea and Asia will successfully bring innovative therapies to Korean patients and gradually build the company's reputation

    .
    "


    Ms.
    Minyoung Kim said: "I really appreciate Deck's promising product pipeline and excellent team

    .
    I am very happy to be able to develop the Korean business with Deck's team and bring innovative drugs to Korean patients

    .
    "


    Minyoung received a Bachelor of Science degree in Pharmacy from Seoul National University and an MBA from Helsinki School of Economics (now Aalto University)

    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.